U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H23N5O2.ClH
Molecular Weight 365.858
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SUNEPITRON HYDROCHLORIDE

SMILES

Cl.[H][C@@]12CC[C@H](CN3C(=O)CCC3=O)CN1CCN(C2)C4=NC=CC=N4

InChI

InChIKey=HWGPYTRJVVMHGT-IODNYQNNSA-N
InChI=1S/C17H23N5O2.ClH/c23-15-4-5-16(24)22(15)11-13-2-3-14-12-21(9-8-20(14)10-13)17-18-6-1-7-19-17;/h1,6-7,13-14H,2-5,8-12H2;1H/t13-,14-;/m0./s1

HIDE SMILES / InChI
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C17H23N5O2
Molecular Weight 329.3968
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including: http://en.pharmacodia.com/web/drug/1_8718.html

Sunepitron (CP-93,393) is an anxiolytic drug with highly selective serotonin 5-hydroxytryptamine 1A autoreceptor agonist, alpha2-adrenergic antagonist, and dopamine D2 agonist properties. Sunepitron hydrochloride had been in Phase III clinical trials by Pfizer for the treatment of anxiety disorder and depression. However, this research has been discontinued.

CNS Activity

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Antagonist
2778
Agonist
2678
 92.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Phase III
656
Unknown

Approved Use

Unknown
Primary
Withdrawn
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.02 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
10.92 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
2.36 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
87.33 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
0.9 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
4.1 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/9571226/
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
SUNEPITRON plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
5 mg single, oral
Dose: 5 mg
Route: oral
Route: single
Dose: 5 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/9571226/
healthy
n = 6
Health Status: healthy
Sex: M
Food Status: UNKNOWN
Population Size: 6
Sources:
https://pubmed.ncbi.nlm.nih.gov/9571226/
Sources:
https://pubmed.ncbi.nlm.nih.gov/9571226/
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG
substrate
1217

OverviewOther

Other InhibitorOther SubstrateOther Inducer
Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
CYP2D6
1217
 major
Sourcing

Sourcing

Vendor/AggregatorIDURL
Axon MedChem
1519
https://www.axonmedchem.com/product/1519
BOC Sciences
148408-65-5
http://www.bocsci.com/description.asp?cas=148408-65-5
Compound Cloud
183092
Compound Cloud
6918176
MolPort
MolPort-042-665-705
https://www.molport.com/shop/molecule-link/MolPort-042-665-705
MuseChem
I009649
https://www.musechem.com/product/I009649.html
Tetrahedron
TS77820
http://www.thsci.com/search.do?q=TS77820
eMolecules
110068823
https://orderbb.emolecules.com/search/#?query=110068823
eMolecules
271446115
https://orderbb.emolecules.com/search/#?query=271446115
eMolecules
301236505
https://orderbb.emolecules.com/search/#?query=301236505
eMolecules
301236761
https://orderbb.emolecules.com/search/#?query=301236761
eMolecules
50580280
https://orderbb.emolecules.com/search/#?query=50580280
mcule
MCULE-1128895085
https://mcule.com/MCULE-1128895085/
mcule
MCULE-2945972636
https://mcule.com/MCULE-2945972636/
PubMed

PubMed

TitleDatePubMed
Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
1998 May
Psychopharmacology of depression in the next millennium.
1999 Jul
Patents

Patents

US5122525
2
US7678363
2

Sample Use Guides

In Vivo Use Guide
The excretion, biotransformation, and pharmacokinetics of Sunepitron (CP-93,393) were investigated in six healthy male volunteers after oral administration of a 5-mg dose of [14C]CP-93,393.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:02:32 GMT 2023
Edited
by admin
on Fri Dec 15 18:02:32 GMT 2023
Record UNII
1NYW5HLO1E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SUNEPITRON HYDROCHLORIDE
USAN  
USAN  
Official Name English
N-((7S,9AS)-OCTAHYDRO-2-(2-PYRIMIDINYL)-2H-PYRIDO(1,2-A)PYRAZIN-7-YL)METHYL)SUCCINIMIDE MONOHYDROCHLORIDE
Common Name English
CP-93393-1
Code English
SUNEPITRON HYDROCHLORIDE [USAN]
Common Name English
CP-93,393-1
Code English
Classification Tree Code System Code
NCI_THESAURUS C47794
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
NCI_THESAURUS C29713
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2111058
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
PUBCHEM
6918176
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
EPA CompTox
DTXSID10869968
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
FDA UNII
1NYW5HLO1E
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
NCI_THESAURUS
C152474
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
CAS
148408-65-5
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
USAN
FF-80
Created by admin on Fri Dec 15 18:02:32 GMT 2023 , Edited by admin on Fri Dec 15 18:02:32 GMT 2023
PRIMARY
Related Record Type Details
Structure of SUNEPITRON
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of SUNEPITRON
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966